Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Lung Cancer (Amsterdam, Netherlands)|May 7, 2013
Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601Shunichi Sugawara, Makoto Maemondo, Motoko Tachihara, et al.
International Cancer Conference Journal|June 1, 2019
Pseudomyxoma peritonei due to low-grade appendiceal mucinous neoplasm with symptoms of inguinal hernia and uterine prolapse: a case report and review of the literatureHideki Watanabe, Yoshiaki Miyasaka, Kana Watanabe, et al.
The Oncologist|April 1, 2014
Randomized phase II trial comparing carboplatin plus weekly paclitaxel and docetaxel alone in elderly patients with advanced non-small cell lung cancer: north japan lung cancer group trial 0801Makoto Maemondo, Akira Inoue, Shunichi Sugawara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated <i>EGFR</i>Eisaku Miyauchi, Satoshi Morita, Atsushi Nakamura, et al.
Medical Oncology (Northwood, London, England)|June 30, 2025
Phase II study of carboplatin + weekly paclitaxel for advanced lung squamous cell carcinoma with idiopathic interstitial pneumonia (Hanshin Cancer Group IP001)Hidekazu Suzuki, Akito Hata, Takaaki Tokito, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2012
Identification of a novel benzimidazole derivative as a highly potent NPY Y5 receptor antagonist with an anti-obesity profileYuusuke Tamura, Kyouhei Hayashi, Naoki Omori, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Re-biopsy status among non-small cell lung cancer patients in Japan: A retrospective studyKaname Nosaki, Miyako Satouchi, Takayasu Kurata, et al.
Ebiomedicine|January 22, 2019
Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistanceKoutaroh Okada, Mitsugu Araki, Takuya Sakashita, et al.
JTO Clinical and Research Reports|May 6, 2024
Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060Takehiro Tozuka, Yuji Minegishi, Ou Yamaguchi, et al.
Translational Lung Cancer Research|March 15, 2021
Randomized phase II trial of uracil/tegafur and cisplatin versus pemetrexed and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-squamous non-small cell lung cancer: NJLCG1001Kana Watanabe, Yukihiro Toi, Atsushi Nakamura, et al.
Pageof 7